XML 30 R20.htm IDEA: XBRL DOCUMENT v3.19.2

Revenues (Tables)

6 Months Ended

Jun. 30, 2019

Segment Reporting [Abstract]

Summary of net revenue

The Company’s net revenues consisted of the following for the three and six months ended June 30, 2019 and 2018:

			Three months ended June 30,																		Six months ended June 30,
			2019						2018						2019						2018
Products:
Acetadote			$	983,473					$	841,431					$	1,832,976					$	2,115,741
Omeclamox-Pak			478,604						89,952						678,141						231,344
Kristalose			3,476,807						3,203,743						6,785,050						6,473,097
Vaprisol			212,526						1,685,900						499,202						1,779,790
Caldolor			1,054,718						1,101,023						2,372,599						2,140,771
Ethyol			2,008,247						2,809,691						5,099,429						5,065,764
Totect			154,910						269,190						235,805						681,964
Vibativ			2,599,280						—						4,659,471						—
Other			612,035						162,794						1,320,674						262,858
Total net revenues			$	11,580,600					$	10,163,724					$	23,483,347					$	18,751,329

X

- Definition

Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e9031-108599

+ Details

Name:	us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration